Carmen Medina
Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics
Herausgeber: Medina, Carmen
Carmen Medina
Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics
Herausgeber: Medina, Carmen
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This text lists the necessary steps for meeting compliance requirements during the drug development process. It presents comprehensive approaches for validating analytical methods for pharmaceutical applications.
Andere Kunden interessierten sich auch für
- Good Manufacturing Practices for Pharmaceuticals, Seventh Edition236,99 €
- Donald C. SingerLaboratory Auditing for Quality and Regulatory Compliance250,99 €
- David StokesTesting Computers Systems for FDA/MHRA Compliance215,99 €
- New Frontiers in Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases77,99 €
- Handbook of Biologics for Rheumatological Disorders118,99 €
- Handbook of Biologics for Rheumatological Disorders87,99 €
- Biologics to Treat Substance Use Disorders75,99 €
-
-
-
This text lists the necessary steps for meeting compliance requirements during the drug development process. It presents comprehensive approaches for validating analytical methods for pharmaceutical applications.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: CRC Press
- Seitenzahl: 696
- Erscheinungstermin: 9. Dezember 2003
- Englisch
- Abmessung: 235mm x 157mm x 42mm
- Gewicht: 1142g
- ISBN-13: 9780824740788
- ISBN-10: 0824740785
- Artikelnr.: 21958615
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: CRC Press
- Seitenzahl: 696
- Erscheinungstermin: 9. Dezember 2003
- Englisch
- Abmessung: 235mm x 157mm x 42mm
- Gewicht: 1142g
- ISBN-13: 9780824740788
- ISBN-10: 0824740785
- Artikelnr.: 21958615
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Carmen Medina
Regulatory submissions
Patricia Fritz and Anisa Dhalla; compliance requirements during the drug development process
Martin D. Hynes; validation - a new perspective
James Agalloco; validating analytical methods for pharmaceutical applications - a comprehensive approach
Paul A. Winslow and Richard F. Meyer; the stability testing programme
Maria Geigel; computer validation - a compliance focus
Timothy Horgan and Timothy Carey; compliance issues associated with cleaning in the pharmaceutical industry
William E. Hall; the batch record - a blueprint for quality and compliance
John Fugate; change management - a far reaching
comprehensive and integrated system
Susan Freeman; the vendor qualification programme
Eizabeth M. Troll and Karen L. Hughes; handling laboratory and manufacturing deviations
Robert B. Kirsch; the internal audit programme - a quality assessment
Graham Bunn; pre-approval inspections - the critical compliance path to success
Martin D. Hynes; international compliance issues and trends
Alan G. Minsk; strategic planning for compliance and regulatory defensiveness
Ron Johnson; unique and unprecedented compliance challenges in the biologics area
Anne Hoppe and Curtiss Scribner; the impact of total quality performance on compliance
Carmen Medina
Judith Beach
Valerie Palumbo and Douglas B. Poucher.
Patricia Fritz and Anisa Dhalla; compliance requirements during the drug development process
Martin D. Hynes; validation - a new perspective
James Agalloco; validating analytical methods for pharmaceutical applications - a comprehensive approach
Paul A. Winslow and Richard F. Meyer; the stability testing programme
Maria Geigel; computer validation - a compliance focus
Timothy Horgan and Timothy Carey; compliance issues associated with cleaning in the pharmaceutical industry
William E. Hall; the batch record - a blueprint for quality and compliance
John Fugate; change management - a far reaching
comprehensive and integrated system
Susan Freeman; the vendor qualification programme
Eizabeth M. Troll and Karen L. Hughes; handling laboratory and manufacturing deviations
Robert B. Kirsch; the internal audit programme - a quality assessment
Graham Bunn; pre-approval inspections - the critical compliance path to success
Martin D. Hynes; international compliance issues and trends
Alan G. Minsk; strategic planning for compliance and regulatory defensiveness
Ron Johnson; unique and unprecedented compliance challenges in the biologics area
Anne Hoppe and Curtiss Scribner; the impact of total quality performance on compliance
Carmen Medina
Judith Beach
Valerie Palumbo and Douglas B. Poucher.
Regulatory submissions
Patricia Fritz and Anisa Dhalla; compliance requirements during the drug development process
Martin D. Hynes; validation - a new perspective
James Agalloco; validating analytical methods for pharmaceutical applications - a comprehensive approach
Paul A. Winslow and Richard F. Meyer; the stability testing programme
Maria Geigel; computer validation - a compliance focus
Timothy Horgan and Timothy Carey; compliance issues associated with cleaning in the pharmaceutical industry
William E. Hall; the batch record - a blueprint for quality and compliance
John Fugate; change management - a far reaching
comprehensive and integrated system
Susan Freeman; the vendor qualification programme
Eizabeth M. Troll and Karen L. Hughes; handling laboratory and manufacturing deviations
Robert B. Kirsch; the internal audit programme - a quality assessment
Graham Bunn; pre-approval inspections - the critical compliance path to success
Martin D. Hynes; international compliance issues and trends
Alan G. Minsk; strategic planning for compliance and regulatory defensiveness
Ron Johnson; unique and unprecedented compliance challenges in the biologics area
Anne Hoppe and Curtiss Scribner; the impact of total quality performance on compliance
Carmen Medina
Judith Beach
Valerie Palumbo and Douglas B. Poucher.
Patricia Fritz and Anisa Dhalla; compliance requirements during the drug development process
Martin D. Hynes; validation - a new perspective
James Agalloco; validating analytical methods for pharmaceutical applications - a comprehensive approach
Paul A. Winslow and Richard F. Meyer; the stability testing programme
Maria Geigel; computer validation - a compliance focus
Timothy Horgan and Timothy Carey; compliance issues associated with cleaning in the pharmaceutical industry
William E. Hall; the batch record - a blueprint for quality and compliance
John Fugate; change management - a far reaching
comprehensive and integrated system
Susan Freeman; the vendor qualification programme
Eizabeth M. Troll and Karen L. Hughes; handling laboratory and manufacturing deviations
Robert B. Kirsch; the internal audit programme - a quality assessment
Graham Bunn; pre-approval inspections - the critical compliance path to success
Martin D. Hynes; international compliance issues and trends
Alan G. Minsk; strategic planning for compliance and regulatory defensiveness
Ron Johnson; unique and unprecedented compliance challenges in the biologics area
Anne Hoppe and Curtiss Scribner; the impact of total quality performance on compliance
Carmen Medina
Judith Beach
Valerie Palumbo and Douglas B. Poucher.